Publications

Check Out What’s Happening at Proteocyte.

Select Publications

1. Darling, MR et al. Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic Grading Systems Versus S100A7 Immunohistochemical Signature-based Grading. 2023. doi: 10.1097/PAI.0000000000001132

2. Renick, B et al. Using an AI-Assisted Subcellular S100A7 Bioprotein Assay to Manage Oral Potentially Malignant Disorders/Pre-Cancers. 2023. Oral Health.

3. Pritzker, KPH et al. Oral Potentially Malignant Disorders (OPMD): What is the Clinical Utility of Dysplasia Grade? 2021. Expert Review of Molecular Diagnostics. doi: 10.1080/14737159.2021.1898949

4. Darling, MR et al. Psoriasin: A New Biomarker in the Identification of Cancer Risk in Oral Lesions. 2018. Oral Health.

5. Hwang, JTK et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. 2017. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. doi: 10.1016/j.oooo/2016.11.004

6. Chauhan, SS et al. Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. 2015. Oncogenesis. doi: 10.1038/oncsis.2015.7

7. Kaur, J et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. 2013. Int J Cancer. doi: 10.1002/ijc.28473

8. Tripathi, SC et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. 2010. PLoS One. doi: https://dx.doi.org/10.1371/journal.pone.0011939